Skip to Main Content

Paper Details

Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
3
2022
PATIENTS, Patients, aUC, advanced urothelial cancer, advanced urothelial carcinoma, patients, programmed-death ligand-1
Author NameAffiliation
Neeraj AgarwalUniversity of Utah
Jure MurgicUniversity Hospital Center Sestre Milosrdnice
Alexandra DrakakiDavid Geffen School of Medicine at university of california los angeles
Evan Y YuUniversity of Washington
Evan Y YuClinical Research Division, Fred Hutchinson Cancer Research Center
Jonathan L WrightUniversity of Washington
  • 1 - 6

Datasets

Release 1.2